Cambridge Investment Research Advisors Inc. Acquires 1,838 Shares of CIGNA Co. (CI)
Cambridge Investment Research Advisors Inc. increased its holdings in shares of CIGNA Co. (NYSE:CI) by 27.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,455 shares of the health services provider’s stock after purchasing an additional 1,838 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in CIGNA were worth $1,761,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in CI. Flagship Harbor Advisors LLC purchased a new position in shares of CIGNA in the second quarter worth $102,000. Sun Life Financial INC raised its holdings in shares of CIGNA by 254.3% in the second quarter. Sun Life Financial INC now owns 659 shares of the health services provider’s stock worth $112,000 after buying an additional 473 shares during the last quarter. LFA Lugano Financial Advisors SA purchased a new position in shares of CIGNA in the third quarter worth $116,000. Migdal Insurance & Financial Holdings Ltd. raised its holdings in shares of CIGNA by 3,122.7% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 709 shares of the health services provider’s stock worth $120,000 after buying an additional 687 shares during the last quarter. Finally, Moneta Group Investment Advisors LLC raised its holdings in shares of CIGNA by 98.7% in the second quarter. Moneta Group Investment Advisors LLC now owns 785 shares of the health services provider’s stock worth $133,000 after buying an additional 390 shares during the last quarter. Hedge funds and other institutional investors own 89.50% of the company’s stock.
In related news, Director William D. Zollars sold 238 shares of the firm’s stock in a transaction on Friday, September 14th. The shares were sold at an average price of $193.70, for a total transaction of $46,100.60. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jason D. Sadler sold 21,189 shares of the firm’s stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $212.99, for a total transaction of $4,513,045.11. Following the sale, the insider now owns 41,966 shares in the company, valued at approximately $8,938,338.34. The disclosure for this sale can be found here. In the last three months, insiders have sold 24,252 shares of company stock valued at $5,164,402. 1.10% of the stock is currently owned by corporate insiders.
Shares of CIGNA stock opened at $213.72 on Monday. The company has a debt-to-equity ratio of 1.61, a current ratio of 0.98 and a quick ratio of 0.98. CIGNA Co. has a 1 year low of $163.02 and a 1 year high of $227.13. The firm has a market cap of $52.05 billion, a P/E ratio of 20.43, a price-to-earnings-growth ratio of 1.21 and a beta of 0.58.
CIGNA (NYSE:CI) last issued its earnings results on Thursday, November 1st. The health services provider reported $3.84 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.45 by $0.39. CIGNA had a net margin of 6.15% and a return on equity of 23.31%. The firm had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.19 billion. During the same quarter last year, the company posted $2.83 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. As a group, equities analysts anticipate that CIGNA Co. will post 14.35 earnings per share for the current fiscal year.
CIGNA Company Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Further Reading: Day Trading – Risk Worth the Reward?
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.